m+Medelevator.RU
← Поиск публикаций
Technology in cancer research & treatment · 2026

Whole-Field Continuous Wave Diffuse Reflectance Imaging for Breast Lesion Characterization: Clinical Results.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Carbone Nicolás A, Vera Demián A, Waks-Serra M Victoria, García Héctor A, Iriarte Daniela I, Pomarico Juan A, Fuentes Nora, Renati María E, Capellino Pablo H, Osses Romina, Pardini Pamela A, Hope Inés

Аннотация

ObjectiveThis work introduces MamoRef, an innovative whole-field, near infrared spectroscopy based device for adjunctive breast examination, aiming to help classify benign and malignant lesions in women. Utilizing low-power, non-ionizing red and near-infrared lasers, it provides metabolic information to aid physicians in characterizing lesions in BI-RADS II to IV patients, offering a non-invasive screening alternative.ApproachClinical studies were conducted, benchmarking MamoRef against conventional imaging and core biopsies. The device generates 2D maps of relative oxyhemoglobin, deoxyhemoglobin, and oxygen saturation. NIRS-specialized professionals, with basic clinical training, independently scored MamoRef images using a 6-point scale analog to BI-RADS. Scores were averaged and normalized for biopsy comparison.Main resultsThe studied clinical cases show promising outcomes. For neoproliferative lesions, MamoRef images reveals high deoxygenated hemoglobin and diffuse high oxygenated/total hemoglobin, suggesting neovascularization around necrotic tissue. Preliminary receiver operating characteristic analysis yielded an area under the curve of 0.77. At a 0.6 threshold, MamoRef showed 70% accuracy and 74% specificity.SignificancePreliminary results suggest MamoRef can potentially differentiate benign from malignant lesions detected by standard imaging. Trained clinicians might detect and characterize lesions using these metabolic maps. Further larger-scale studies are needed to validate these findings and improve the technology, positioning MamoRef as a potential low-cost, accessible adjunctive screening tool.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты